Author:
Rej Abhinandan,Paladhi Ankush,Daripa Samrat,Sarkar Debanjan,Bhattacharyya Sankar,Mondal Indrani,Hira Sumit Kumar
Funder
University of Burdwan
Department of Science and Technology, Ministry of Science and Technology, India
Council of Scientific and Industrial Research, India
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference51 articles.
1. R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer statistics, 2022, CA: A Cancer Journal for Clinicians 72(1) (2022) 7-33.
2. Non-Hodgkin lymphoma;Armitage;The Lancet,2017
3. Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma;Nastoupil;eJHaem,2022
4. The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questions;Jurczak;Future Oncology,2018
5. Advances in targeted therapy for malignant lymphoma;Wang;Signal Transduction and Targeted Therapy,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献